242 related articles for article (PubMed ID: 21537045)
1. Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.
Hendrickson WK; Flavin R; Kasperzyk JL; Fiorentino M; Fang F; Lis R; Fiore C; Penney KL; Ma J; Kantoff PW; Stampfer MJ; Loda M; Mucci LA; Giovannucci E
J Clin Oncol; 2011 Jun; 29(17):2378-85. PubMed ID: 21537045
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Sterol-27-Hydroxylase (
Khan NA; Stopsack KH; Allott EH; Gerke T; Giovannucci EL; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1052-1058. PubMed ID: 30867220
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract][Full Text] [Related]
7. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue.
Epstein MM; Andrén O; Kasperzyk JL; Shui IM; Penney KL; Fall K; Rider JR; Stampfer MJ; Andersson SO; Giovannucci E; Mucci LA
Cancer Causes Control; 2012 Aug; 23(8):1359-66. PubMed ID: 22710747
[TBL] [Abstract][Full Text] [Related]
8. Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.
Ahearn TU; Tchrakian N; Wilson KM; Lis R; Nuttall E; Sesso HD; Loda M; Giovannucci E; Mucci LA; Finn S; Shui IM
J Clin Endocrinol Metab; 2016 Jun; 101(6):2520-7. PubMed ID: 27115058
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F; Kasperzyk JL; Shui I; Hendrickson W; Hollis BW; Fall K; Ma J; Gaziano JM; Stampfer MJ; Mucci LA; Giovannucci E
PLoS One; 2011 Apr; 6(4):e18625. PubMed ID: 21494639
[TBL] [Abstract][Full Text] [Related]
10. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
Huang SP; Huang CY; Wu WJ; Pu YS; Chen J; Chen YY; Yu CC; Wu TT; Wang JS; Lee YH; Huang JK; Huang CH; Wu MT
Int J Cancer; 2006 Oct; 119(8):1902-7. PubMed ID: 16708371
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men.
Wang L; Ma J; Manson JE; Buring JE; Gaziano JM; Sesso HD
Eur J Nutr; 2013 Oct; 52(7):1771-9. PubMed ID: 23262750
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor polymorphisms and cancer.
Gandini S; Gnagnarella P; Serrano D; Pasquali E; Raimondi S
Adv Exp Med Biol; 2014; 810():69-105. PubMed ID: 25207361
[TBL] [Abstract][Full Text] [Related]
14. Reduced vitamin D receptor (VDR) expression and plasma vitamin D levels are associated with aging-related prostate lesions.
Campolina-Silva GH; Maria BT; Mahecha GAB; Oliveira CA
Prostate; 2018 May; 78(7):532-546. PubMed ID: 29508414
[TBL] [Abstract][Full Text] [Related]
15. Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.
Gilbert R; Metcalfe C; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM; Tilling K
Eur J Cancer Prev; 2013 Mar; 22(2):121-5. PubMed ID: 22955340
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.
Mikhak B; Hunter DJ; Spiegelman D; Platz EA; Hollis BW; Giovannucci E
Prostate; 2007 Jun; 67(9):911-23. PubMed ID: 17440943
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.
Chen L; Davey Smith G; Evans DM; Cox A; Lawlor DA; Donovan J; Yuan W; Day IN; Martin RM; Lane A; Rodriguez S; Davis M; Zuccolo L; Collin SM; Hamdy F; Neal D; Lewis SJ
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2874-81. PubMed ID: 19861519
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.
Roberts JM; Martin RS; Piyarathna DB; MacKrell JG; Rocha GV; Dodge JA; Coarfa C; Krishnan V; Rowley DR; Weigel NL
Oncotarget; 2017 Jul; 8(27):44447-44464. PubMed ID: 28591703
[TBL] [Abstract][Full Text] [Related]
20. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
Fedirko V; Riboli E; Tjønneland A; Ferrari P; Olsen A; Bueno-de-Mesquita HB; van Duijnhoven FJ; Norat T; Jansen EH; Dahm CC; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Lukanova A; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Benetou V; Trichopoulos D; Grioni S; Vineis P; Panico S; Palli D; Tumino R; Siersema PD; Peeters PH; Skeie G; Brustad M; Chirlaque MD; Barricarte A; Ramón Quirós J; Sánchez MJ; Dorronsoro M; Bonet C; Palmqvist R; Hallmans G; Key TJ; Crowe F; Khaw KT; Wareham N; Romieu I; McKay J; Wark PA; Romaguera D; Jenab M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):582-93. PubMed ID: 22278364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
